About MOBIUS THERAPEUTICS LLC
Mitosol is an FDA-approved ophthalmic antimetabolite used as an adjunct in glaucoma surgery, known for its compliance with USP 800 standards and patented closed-system preparation and disposal.
FDA-approved ophthalmic MMC formulationOn-demand reconstitution system with immediacy and precisionUSP 800 compliant system for containment and disposalPatented closed-system transfer device (CSTD) for minimizing risk of breakage, leakage, and exposureRoom temperature shelf stability for up to 24 months
Is this your company?
Claim MOBIUS THERAPEUTICS LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim MOBIUS THERAPEUTICS LLC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.